Adverse drug reactions in paediatrics: Are we getting the full picture?

Journal of Pharmacy Practice and Research

Volumn 33, Issue 2, 2003, Pages 106-110

  Easton Carter, Kylie L ^a,c   Chapman, Colin B ^a   Brien, Jo Anne E ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c National Prescribing Service Limited   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ATRACURIUM; CEFAZOLIN; CEFPIROME; CHLORAMPHENICOL; CODEINE; COTRIMOXAZOLE; DIAZEPAM; DROPERIDOL; DRUG; ERYTHROMYCIN; FUROSEMIDE; IBUPROFEN; METRONIDAZOLE; MIDAZOLAM; MORPHINE; PAMIDRONIC ACID; PENICILLIN G; PETHIDINE; PROCHLORPERAZINE; PROPOFOL; ROCURONIUM; SALBUTAMOL; TETRACAINE; THIOPENTAL; TIMENTIN; VALPROIC ACID;

ADOLESCENT; ADVERSE DRUG REACTION; ANAPHYLAXIS; ARTICLE; BEHAVIOR DISORDER; BLOOD CLOTTING DISORDER; CHILD; CHILD HOSPITALIZATION; DIARRHEA; DRUG FATALITY; DRUG MONITORING; DYSKINESIA; ELECTROLYTE DISTURBANCE; FEVER; HALLUCINATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT MONITORING; RASH; RESPIRATION DEPRESSION; SEIZURE; VOMITING;

EID: 0041320718     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2003332106     Document Type: Article

References (38)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
2. Roughead E. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999; 19: 19-22.
3. Wilson RM, Runciman WB, Gibberd RW, Harrison BT. Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust 1995; 163: 458-74.
4. Boston Collaborative Drug Surveillance Program of the Boston University Medical Center. Drug Surveillance: problems and Challenges. Pediatr Clin North Am 1972; 19: 117-29.
5. McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898-903.
6. Collins GE, Clay MM, Falletta JM. A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Am J Hosp Pharm 1974; 31: 968-75.
7. Whyte J, Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand 1977; 66: 767-75.
8. Mitchell AA, Goldman P, Shapiro S, Slone D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196-204.
9. Aranda JV, Portuguez-Malavasi A, Collinge JM, Germanson T, Outerbridege EW. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther 1982; 5: 173-84.
10. Aranda JM. Factors associated with adverse drug reactions in the newborn. Pediatr Pharmacol 1983; 3: 245-9.
11. Choonara IA, Harris F. Adverse drug reactions in medical inpatients. Arch Dis Child 1984; 59: 578-80.
12. Dharnidharka VR, Kandoth PN, Anand RK. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance. Indian Pediatr 1993; 30: 745-51.
13. Gill AM, Leach HJ, Barker C, Nunn AJ, Choonara I. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 1995; 84: 438-41.
14. Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 1998; 36: 530-3.
15. Carleton B, Poole R, Milton J, Travis J, Grinder D. The pediatric adverse drug reaction reporting system. J Pediatr Pharm Pract 1999; 4: 284-307.
16. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 1999; 88: 965-8.
17. Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681-8.
18. Conroy S, Choonara I, Impicciatore P, Mohn A, Amell H, Rane A. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320: 79-82.
19. Working Party on Registration of Drugs for Use in Children. Report of the Working Party on Registration of Drugs for Use in Children. Canberra: Australian Drug Evaluation Committee; 1997.
20. Australian Association of Paediatric Teaching Centres. Policies 1997: Pharmaceuticals for Children. Deakin West, Canberra: The Association; 1997.
21. Turner S. Unregistered and off-label drug use in paediatric inpatients. Aust J Hosp Pharm 1999; 29: 165-8.
22. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998; 316: 343-5.
23. World Health Organisation (WHO). World Health Organisation Technical Report No. 498. Geneva, Switzerland: WHO; 1972.
24. US Department of Health and Human Services (DHHS). The International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM). 3rd ed. Bethesda, Md: DHHS; 1989.
25. National Centre for Classification in Health. ICD-10-AM Tabular list of procedures (MBS-Extended). July 1998 ed. Sydney: Faculty of Health Sciences, University of Sydney; 1998.
26. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
27. Colodny L, Spillane J. Towards increasing reporting of adverse drug reactions. Hosp Pharm 1999; 34: 1175-89.
28. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
29. Easton-Carter K. The consequences of drug related problems in paediatrics [PhD thesis]. Melbourne: Victorian College of Pharmacy, Monash University; 2001.
30. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. East Norwalk: Appleton & Lange; 1994. p, 344.
31. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5: 305-14.
32. Venulet J, Ham MT. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 1996; 34: 112-29.
33. Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42: 407-10.
34. van den Bemt PMLA, Egberts TCG, de Jong-van den Berg LTW, Brouwers JRBJ. Drug-related problems in hospitalised patients. Drug Saf 2000; 22: 321-33.
35. Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 1977; 34: 931-6.
36. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring - cost and benefit considerations part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf 1997; 6 (suppl.3): S71-S77.
37. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Coding drug-related admissions in medical records: is it adequate for monitoring the quality of medication use? Aust J Hosp Pharm 1998; 28: 7-12.
38. Raymond PM, Robertson MB. Adverse drug reaction reporting in Melbourne teaching hospitals. Aust J Hosp Pharm 1994; 24: 237-42.